Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer

Fig. 6

Therapeutic effects of NV-Dxl in the mouse model of subcutaneous prostate cancer. a The representative in vivo Luc2 bioluminescence images before and by the end of treatments. b The quantification of weekly in vivo Luc2 bioluminescence intensities during treatment. c Tumor sizes were measured every 4 days till the end point of 24 days after treatment. d, e Tumors were harvested and weighed at the end point. f The blood was collected at the end point to count white blood cell (WBC). N = 6, *p < 0.05 vs. the free Dxl group and the PBS group; ns, not significant

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512